Kelonia Therapeutics
Private · United States
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
In vivo BCMA CAR-T |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| How it works | Reprograms the patient's own immune T cells | ||||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma in Relapse, Myeloma Multiple and 12 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: Kelonia Therapeutics is private
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev